Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters

Pancreatic cancer is an aggressive malignancy resistant to most conventional and experimental therapies, including conditionally replicative adenoviruses (CRAds). The incorporation of immunostimulatory genes such as interleukin-12 (IL-12) in these viruses may overcome some of their limitations, but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bortolanza, Sergia, Bunuales, Maria, Otano, Itziar, Gonzalez-Aseguinolaza, Gloria, Ortiz-de-Solorzano, Carlos, Perez, Daniel, Prieto, Jesus, Hernandez-Alcoceba, Ruben
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835109/
https://ncbi.nlm.nih.gov/pubmed/19223865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados